LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 135 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,044,992 | -48.4% | 1,876,139 | +8.4% | 0.00% | – |
| Q2 2023 | $3,961,956 | +4.3% | 1,730,112 | +10.6% | 0.00% | – |
| Q1 2023 | $3,798,703 | -34.4% | 1,564,098 | -48.4% | 0.00% | – |
| Q4 2022 | $5,792,934 | +64.9% | 3,032,950 | +107.2% | 0.00% | – |
| Q3 2022 | $3,513,000 | +39.7% | 1,463,569 | +8.3% | 0.00% | – |
| Q2 2022 | $2,515,000 | -9.1% | 1,352,001 | +2.1% | 0.00% | – |
| Q1 2022 | $2,768,000 | -42.2% | 1,324,385 | +9.0% | 0.00% | – |
| Q4 2021 | $4,787,000 | -9.7% | 1,215,018 | +10.3% | 0.00% | – |
| Q3 2021 | $5,299,000 | +11.3% | 1,101,753 | +6.2% | 0.00% | – |
| Q2 2021 | $4,763,000 | +8.1% | 1,037,647 | +38.3% | 0.00% | – |
| Q1 2021 | $4,405,000 | +76.8% | 750,385 | +3.0% | 0.00% | – |
| Q4 2020 | $2,492,000 | +130.7% | 728,594 | -2.8% | 0.00% | – |
| Q3 2020 | $1,080,000 | -27.4% | 749,860 | +0.5% | 0.00% | – |
| Q2 2020 | $1,488,000 | -7.7% | 745,938 | -9.8% | 0.00% | – |
| Q1 2020 | $1,612,000 | -56.7% | 826,817 | -7.7% | 0.00% | – |
| Q4 2019 | $3,719,000 | +29.7% | 896,170 | -5.9% | 0.00% | – |
| Q3 2019 | $2,867,000 | -51.5% | 952,606 | +1.5% | 0.00% | – |
| Q2 2019 | $5,906,000 | +14.0% | 938,952 | +0.8% | 0.00% | – |
| Q1 2019 | $5,180,000 | -57.8% | 931,697 | -49.5% | 0.00% | -100.0% |
| Q4 2018 | $12,261,000 | -54.6% | 1,846,498 | -27.0% | 0.00% | -50.0% |
| Q3 2018 | $26,994,000 | +12.4% | 2,530,044 | +26.5% | 0.00% | 0.0% |
| Q2 2018 | $24,008,000 | +4.9% | 2,000,545 | -25.1% | 0.00% | 0.0% |
| Q1 2018 | $22,891,000 | -0.9% | 2,671,129 | +14.2% | 0.00% | 0.0% |
| Q4 2017 | $23,101,000 | -10.3% | 2,338,034 | +11.6% | 0.00% | 0.0% |
| Q3 2017 | $25,742,000 | -20.5% | 2,094,934 | +6.5% | 0.00% | -33.3% |
| Q2 2017 | $32,363,000 | +37.5% | 1,967,255 | +19.9% | 0.00% | +50.0% |
| Q1 2017 | $23,536,000 | +6.9% | 1,641,167 | +3.1% | 0.00% | 0.0% |
| Q4 2016 | $22,008,000 | -10.3% | 1,591,365 | +17.2% | 0.00% | 0.0% |
| Q3 2016 | $24,539,000 | +33.3% | 1,357,994 | +5.9% | 0.00% | 0.0% |
| Q2 2016 | $18,406,000 | +27.4% | 1,282,614 | +6.1% | 0.00% | 0.0% |
| Q1 2016 | $14,450,000 | -22.5% | 1,209,379 | -13.6% | 0.00% | 0.0% |
| Q4 2015 | $18,634,000 | -30.0% | 1,399,773 | -43.5% | 0.00% | -33.3% |
| Q3 2015 | $26,633,000 | +491.3% | 2,479,555 | +343.3% | 0.00% | – |
| Q2 2015 | $4,504,000 | – | 559,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |